AMERIPRISE FINANCIAL INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,244,758
+4.1%
80,463
+5.7%
0.00%
Q2 2023$1,195,696
-0.5%
76,110
+4.4%
0.00%
Q1 2023$1,201,482
-22.0%
72,905
-26.2%
0.00%
-100.0%
Q4 2022$1,541,000
+6.3%
98,823
-11.6%
0.00%0.0%
Q3 2022$1,449,000
+72.5%
111,782
+86.7%
0.00%
Q2 2022$840,000
-27.3%
59,865
-25.8%
0.00%
Q1 2022$1,155,000
+30.5%
80,683
+24.9%
0.00%
Q4 2021$885,000
-25.8%
64,586
-11.4%
0.00%
Q3 2021$1,193,000
+13.8%
72,902
+17.1%
0.00%
Q2 2021$1,048,000
-6.0%
62,265
+2.5%
0.00%
Q1 2021$1,115,000
+38.2%
60,757
+37.2%
0.00%
Q4 2020$807,000
-22.0%
44,275
-23.7%
0.00%
Q3 2020$1,035,000
-68.5%
58,025
-68.4%
0.00%
-100.0%
Q2 2020$3,288,000
+377.9%
183,343
+304.2%
0.00%
Q1 2020$688,000
-23.9%
45,354
-0.9%
0.00%
Q4 2019$904,000
+6.2%
45,784
-7.6%
0.00%
Q3 2019$851,000
-12.2%
49,533
-9.5%
0.00%
Q2 2019$969,000
-62.0%
54,752
-56.2%
0.00%
-100.0%
Q1 2019$2,547,000
+34.1%
125,059
+10.7%
0.00%0.0%
Q4 2018$1,900,000
+258.5%
112,990
+342.6%
0.00%
Q4 2016$530,000
+117.2%
25,528
+150.7%
0.00%
Q3 2016$244,000
-15.6%
10,181
-24.1%
0.00%
Q2 2016$289,000
-9.4%
13,413
-4.1%
0.00%
Q1 2016$319,000
-26.2%
13,985
-18.9%
0.00%
Q4 2015$432,000
+24.9%
17,238
+9.1%
0.00%
Q3 2015$346,000
-16.4%
15,807
-6.4%
0.00%
Q2 2015$414,000
-8.4%
16,896
-6.6%
0.00%
Q1 2015$452,000
+31.8%
18,088
+10.0%
0.00%
Q4 2014$343,000
+134.9%
16,438
+145.5%
0.00%
Q3 2014$146,000
-18.9%
6,697
-13.7%
0.00%
Q2 2014$180,000
-12.2%
7,758
-10.1%
0.00%
Q1 2014$205,000
+1.5%
8,633
-1.8%
0.00%
Q4 2013$202,000
+7.4%
8,788
+10.5%
0.00%
Q3 2013$188,000
+28.8%
7,953
+25.6%
0.00%
Q2 2013$146,0006,3330.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders